Mylan’s Eplerenone Among Seven US Divestments For Viatris
But FTC-Directed Product Divestitures Come Under Fire
Mylan and Pfizer’s Upjohn must make a total of seven product divestments to close on their proposed combination to Viatris, while conditions were placed on a further three products. The FTC’s means of remedying competition concerns via product divestitures has once again come under fire.
